| Shelley Xinran Mo, MD | |
|
485 Royer Dr Ste 103, Lancaster, PA 17601-5102 | |
| (717) 560-4020 | |
| Not Available |
| Full Name | Shelley Xinran Mo |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 7 Years |
| Location | 485 Royer Dr Ste 103, Lancaster, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265963458 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207WX0009X | Ophthalmology - Glaucoma Specialist | MD473423 (Pennsylvania) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eye Doctors Of Lancaster Ltd | 9032108675 | 7 |
News Archive
In its November meeting, the Pharmaceutical Benefits Advisory Committee (PBAC) will consider Novo Nordisk's second-to-market glucagon-like peptide-1 (GLP-1) agonist Victoza for reimbursement, which would be essential in order for the drug to compete effectively with Eli Lilly's Byetta. However, its chances of success are uncertain, considering that it took three years to get Byetta on the Pharmaceutical Benefits Scheme (PBS).
The Health and Human Services secretary was invited in January to address graduates of the Public Policy Institute at the Jesuit institution.
Many surgical patients don't know that it's advisable to stop taking complementary and alternative medicine at least one to three weeks prior to surgery. During Patient Safety Awareness Week, March 13-19, 2016, the American Association of Nurse Anesthetists is reminding patients to bring a list of all medications - prescription or not - to their pre-anesthesia interview, and to share details about their medication use with their Certified Registered Nurse Anesthetist or other anesthesia professional.
Industrial Biotechnology Corporation has announced the expansion of their License Agreement with Isis Innovation Limited, the technology transfer company of Oxford University.
Seal Shield LLC (Jacksonville, FL), today announced the new Airocide DS air purifier. The Airocide DS is a table top or bed side air purification product that uses a unique photocatalytic biocide reactor to eliminate viral, fungal and bacterial pathogens from the air. Developed by NASA, Airocide converts dangerous bacteria, virus and destructive VOC's into harmless water vapor without producing ozone or other harmful byproducts.
› Verified 4 days ago
| Entity Name | University Of Pittsburgh Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619935004 PECOS PAC ID: 8729990239 Enrollment ID: O20040308000883 |
News Archive
In its November meeting, the Pharmaceutical Benefits Advisory Committee (PBAC) will consider Novo Nordisk's second-to-market glucagon-like peptide-1 (GLP-1) agonist Victoza for reimbursement, which would be essential in order for the drug to compete effectively with Eli Lilly's Byetta. However, its chances of success are uncertain, considering that it took three years to get Byetta on the Pharmaceutical Benefits Scheme (PBS).
The Health and Human Services secretary was invited in January to address graduates of the Public Policy Institute at the Jesuit institution.
Many surgical patients don't know that it's advisable to stop taking complementary and alternative medicine at least one to three weeks prior to surgery. During Patient Safety Awareness Week, March 13-19, 2016, the American Association of Nurse Anesthetists is reminding patients to bring a list of all medications - prescription or not - to their pre-anesthesia interview, and to share details about their medication use with their Certified Registered Nurse Anesthetist or other anesthesia professional.
Industrial Biotechnology Corporation has announced the expansion of their License Agreement with Isis Innovation Limited, the technology transfer company of Oxford University.
Seal Shield LLC (Jacksonville, FL), today announced the new Airocide DS air purifier. The Airocide DS is a table top or bed side air purification product that uses a unique photocatalytic biocide reactor to eliminate viral, fungal and bacterial pathogens from the air. Developed by NASA, Airocide converts dangerous bacteria, virus and destructive VOC's into harmless water vapor without producing ozone or other harmful byproducts.
› Verified 4 days ago
| Entity Name | Eye Doctors Of Lancaster Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235145665 PECOS PAC ID: 9032108675 Enrollment ID: O20040510000661 |
News Archive
In its November meeting, the Pharmaceutical Benefits Advisory Committee (PBAC) will consider Novo Nordisk's second-to-market glucagon-like peptide-1 (GLP-1) agonist Victoza for reimbursement, which would be essential in order for the drug to compete effectively with Eli Lilly's Byetta. However, its chances of success are uncertain, considering that it took three years to get Byetta on the Pharmaceutical Benefits Scheme (PBS).
The Health and Human Services secretary was invited in January to address graduates of the Public Policy Institute at the Jesuit institution.
Many surgical patients don't know that it's advisable to stop taking complementary and alternative medicine at least one to three weeks prior to surgery. During Patient Safety Awareness Week, March 13-19, 2016, the American Association of Nurse Anesthetists is reminding patients to bring a list of all medications - prescription or not - to their pre-anesthesia interview, and to share details about their medication use with their Certified Registered Nurse Anesthetist or other anesthesia professional.
Industrial Biotechnology Corporation has announced the expansion of their License Agreement with Isis Innovation Limited, the technology transfer company of Oxford University.
Seal Shield LLC (Jacksonville, FL), today announced the new Airocide DS air purifier. The Airocide DS is a table top or bed side air purification product that uses a unique photocatalytic biocide reactor to eliminate viral, fungal and bacterial pathogens from the air. Developed by NASA, Airocide converts dangerous bacteria, virus and destructive VOC's into harmless water vapor without producing ozone or other harmful byproducts.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shelley Xinran Mo, MD 485 Royer Dr Ste 103, Lancaster, PA 17601-5102 Ph: (717) 560-4020 | Shelley Xinran Mo, MD 485 Royer Dr Ste 103, Lancaster, PA 17601-5102 Ph: (717) 560-4020 |
News Archive
In its November meeting, the Pharmaceutical Benefits Advisory Committee (PBAC) will consider Novo Nordisk's second-to-market glucagon-like peptide-1 (GLP-1) agonist Victoza for reimbursement, which would be essential in order for the drug to compete effectively with Eli Lilly's Byetta. However, its chances of success are uncertain, considering that it took three years to get Byetta on the Pharmaceutical Benefits Scheme (PBS).
The Health and Human Services secretary was invited in January to address graduates of the Public Policy Institute at the Jesuit institution.
Many surgical patients don't know that it's advisable to stop taking complementary and alternative medicine at least one to three weeks prior to surgery. During Patient Safety Awareness Week, March 13-19, 2016, the American Association of Nurse Anesthetists is reminding patients to bring a list of all medications - prescription or not - to their pre-anesthesia interview, and to share details about their medication use with their Certified Registered Nurse Anesthetist or other anesthesia professional.
Industrial Biotechnology Corporation has announced the expansion of their License Agreement with Isis Innovation Limited, the technology transfer company of Oxford University.
Seal Shield LLC (Jacksonville, FL), today announced the new Airocide DS air purifier. The Airocide DS is a table top or bed side air purification product that uses a unique photocatalytic biocide reactor to eliminate viral, fungal and bacterial pathogens from the air. Developed by NASA, Airocide converts dangerous bacteria, virus and destructive VOC's into harmless water vapor without producing ozone or other harmful byproducts.
› Verified 4 days ago
John William Sharp Jr., MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1254 Lititz Pike, Lancaster, PA 17601 Phone: 717-397-4724 Fax: 717-397-6687 | |
William M Spitler Iii, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2108 Harrisburg Pike, Ste 100, Lancaster, PA 17601 Phone: 717-544-3900 Fax: 717-544-3910 | |
Dr. Patrick T Tiedeken, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2170 Noll Dr Ste 400, Lancaster, PA 17603 Phone: 717-417-8950 | |
Dr. Justin L Cappiello, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 324 N Duke St, Lancaster, PA 17603 Phone: 717-394-6808 Fax: 717-299-4133 | |
Adam Ryan Thode, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2115 Noll Dr, Lancaster, PA 17603 Phone: 717-393-7980 Fax: 717-509-5079 | |
Dina Y. Gewaily, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2150 Harrisburg Pike, Ste 370, Lancaster, PA 17601 Phone: 717-399-8790 Fax: 717-399-3279 | |
Pierre K Palandjian, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1254 Lititz Pike, Lancaster, PA 17601 Phone: 717-397-4724 Fax: 717-397-6687 |